Title: Role of matrix metalloproteinase -9 in progression of tuberculous meningitis: A pilot study in patients at different stages of the disease

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Majeed, S ^a   Singh, P ^a   Sharma, N ^a   Sharma, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antitubercular drugs; Inflammation; Matrixmetalloproteinase 9; Mycobacterium tuberculosis; SB 3CT; Tissue inhibitor of metalloproteinase 1; Tuberculous meningitis

Indexed keywords

2 [[(4 PHENOXYPHENYL)SULFONYL]METHYL]THIIRANE; DEXAMETHASONE; GELATINASE B; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE INHIBITOR; SB 3CT COMPOUND; SINGLE HETEROCYCLIC RINGS; SULFONE; TIMP1 PROTEIN, HUMAN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIOMA CELL LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PILOT STUDY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; TUBERCULOUS MENINGITIS; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DRUG EFFECTS; ENZYMOLOGY; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOGENICITY; PATHOPHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DEXAMETHASONE; DISEASE PROGRESSION; FEMALE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; MYCOBACTERIUM TUBERCULOSIS; PILOT PROJECTS; SULFONES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUBERCULOSIS, MENINGEAL;

EID: 84999188166     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1953-9     Document Type: Article

References (25)

1. Thwaites G, Hien T, Thwaites G, Hien T. Tuberculous meningitis: many questions, too few answers. The Lancet Neurology. 2005;4(3):160-170
2. Isabel B. S. RHP. Pathogenesis and Immune Response in Tuberculous Meningitis. J Med Sci. 2014;21(1):4-10.
3. Thwaites GE, Simmons CP, Than Ha Quyen N, Thi Hong Chau T, Phuong Mai P, Thi Dung N, Hoan Phu N, White NP, Tinh Hien T, Farrar JJ. Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis. J Infect Dis. 2003;188(8):1105-15.
4. Rivera-Marrero CA, Schuyler W, Roser S, Ritzenthaler JD, Newburn SA, Roman J. M. Tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms. Am J Physiol Lung Cell Mol Physiol. 2002;282(3):L546-55.
5. Spanos JP, Hsu NJ, Jacobs M. Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis. Front Cell Neurosci. 2015;9:182.
6. Chang JCWA, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN. Effect of mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax. 1996;51:306-11.
7. Sheen P, O'Kane CM, Chaudhary K, Tovar M, Santillan C, Sosa J, Caviedes L, Gilman RH, Stamp G, Friedland JS, et al. High mmp-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J. 2009;33(1):134-41.
8. Li YT, Shen F, Bai JY, Cheng GF. Inhibition of dexamethasone, indomethacin and resveratrol on matrix metalloproteinase-9 and the mechanism of inhibition. Yao Xue Xue Bao. 2003;38(7):501-4.
9. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2002;26(5):602-9.
10. Cui J, Chen S, Zhang C, Meng F, Wu W, Hu R, Hadass O, Lehmidi T, Blair GJ, Lee M, Chang M, Mobashery S, Sun GY, Gu Z. Inhibition of mmp-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener. 2012;7:21.
11. Ranasinghe HS, Scheepens A, Sirimanne E, Mitchell MD, Williams CE, Fraser M. Inhibition of mmp-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor. Dev Neurosci. 2012;34(5):417-27.
12. Mahadevan BMS, Tiroumourougane V, Narahsiman R. Tuberculin reactivity in tuberculous meningitis. Indian J Pediatr. 2005;72:213-5.
13. Matsuura EUF, Hashiguchi T, Fujimoto N, Okada Y, et al. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci. 2000;173:45-52.
14. DE Kleiner SW. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem. 1994;218:325-9.
15. Oliver GWLJ, Stevenson WG, Kleiner DE. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase a and b reverse zymograms. Anal Biochem. 1997;244:161-6.
16. Chanwong S, Maneekarn N, Makonkawkeyoon L, Makonkawkeyoon S. Intracellular growth and drug susceptibility of mycobacterium tuberculosis in macrophages. Tuberculosis (Edinb). 2007;87(2):130-3.
17. Lin CW, Shen SC, Hou WC, Yang LY, Chen YC. Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol Cancer Ther. 2008;7(5):1195-206.
18. Schierloh P, Yokobori N, Aleman M, Landoni V, Geffner L, Musella RM, et al. Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy. Infect Immun. 2007;75(11):5325-37.
19. Lee KY, Kim EH, Yang WS, Ryu H, Cho SN, Lee BI, Heo JH. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci. 2004;220(1-2):73-8.
20. Lammie GHR, Schoeman JF, Donald PR. Tuberculous cerebrovascular disease. J Infect. 2009;59:155-66.
21. Elkington PT, Friedland JS, GCAU. Matrix metalloproteinases in tuberculosis. Eur Respir J. 2011;38:456-64.
22. Yu AE, Hewitt RE, Kleiner DE, Stetler-Stevenson WG. Molecular regulation of cellular invasion--role of gelatinase a and timp-2. Biochem Cell Biol. 1996;74(6):823-31.
23. Harris JE, Green JA, Elkington PT, Friedland JS. Monocytes infected with mycobacterium tuberculosis regulate map kinase-dependent astrocyte mmp-9 secretion. J Leukoc Biol. 2007;81(2):548-56.
24. Harris JE, Nuttall RK, Elkington PT, Green JA, Horncastle DE. Monocyte-astrocyte networks regulate tuberculosis in vitro and in vivo and secretion in central nervous system matrix metalloproteinase gene expression. J Immunol. 2007;178:1199-207.
25. Harkness KA, Adamson P, Sussman JD, Davies-Jones GAB, Greenwood J, Woodroofe MN. Dexamethasone regulation of matrix metalloproteinase expression in cns vascular endothelium. Brain. 2000;123(4):698-709.